To systematically evaluate the risk factors for developing diabetic foot ulcers (DFU).
Methods
The Cochrane Library, PubMed, Web of Science, SinoMed, CNKI, VIP, and Wanfang Data were searched for relevant studies on DFU risk factors, and the search time frame was from database creation to March 2022. Meta-analysis was performed using RevMan 5.3.
Results
A total of 26 publications were included, including 3 cohort studies, 22 case–control studies, and one cross-sectional study. Meta-analysis showed that advanced age [MD = 6.04, 95% CI (3.92, 8.16)], male [OR = 1.84, 95% CI (1.48, 2.29)], elevated body mass index [MD = 1.58, 95% CI (0.47, 2.69)], prolonged duration of diabetes [MD = 2.72, 95% CI (2.33, 3.11)], comorbid nephropathy [OR = 3.15, 95% CI (2.68, 4.60)], comorbid neuropathy [OR = 4.80, 95% CI (2.79, 8.27)], comorbid retinopathy [OR = 3.37, 95% CI (2.26, 5.02)], elevated systolic blood pressure [OR = 8.19, 95% CI (6.33, 10.05)], elevated fasting glucose [MD = 1.60, 95% CI (0.21, 3.00)], elevated glycated hemoglobin [MD = 1.24, 95% CI (0.94, 1.54)], elevated triglycerides [MD = 0.44 (95% CI (0.15, 0.73)], elevated fibrinogen [MD = 1.35, 95% CI (0.62, 2.08)], elevated white blood cell count [MD = 2.56, 95% CI (2.24, 2.88)], elevated C-reactive protein [MD = 15.08, 95% CI (8.03, 22.13)], decreased ankle-brachial ratio [MD = −0.26, 95% CI (−0.36, −0.16)], and decreased total protein levels [MD = −4.58, 95% CI (−6.91, −2.25)] were risk factors for developing DFU (p < 0.05), and increased HDL cholesterol levels [MD = −0.22, 95% CI (−0.36, −0.08)] were protective factor for developing DFU (p < 0.05).
Conclusion
There are many risk factors for developing of ulcers in the diabetic feet, and early prevention and intervention should be performed as early as possible to assess the risk of developing diabetic foot patients.
China Association for the advancement of international healthcare and Diabetes Association. Guidelines for diagnosis and treatment of diabetic foot in China [J]. Chin J Med2017; 97(4): 251–258.
2.
YadavCSrikantiahRMManjrekarP, et al.Assessment of mineral pathophysiology in patients with diabetic foot ulcer.[J]. Biol Trace Elem Res2020; 195(2): 366–372.
3.
RostomADubeCCranneyA, et al.Agency for healthcare research and quality (US)[EB/OL], 2021, pp. 11–21.
4.
LiangYJiangXLLeiY, et al.Significance of 2 tests for type 2 diabetes mellitus with diabetic foot [J]. Lab Med Clinic2013; 10: 1221–1222.
WangRWuJ. Risk factors for diabetic foot ulcers [J]. J Bengbu Med Coll2015; 40(11): 1496–1500.
7.
XiongZYTangZQGuHY. Incidence, healing, recurrence and risk factors of diabetic foot [J]. Chin J Gerontol2019; 39(13): 3121–3123.
8.
ChenGCLiQMYuanM, et al.Influencing factors of diabetic foot ulcers [J]. Chin J Pract Int Med2007; 27(2): 95–97.
9.
ChenLGuanXDuXB. Correlation between IncRNA H19 expression and diabetic foot ulcers in patients with type 2 diabetes mellitus [J]. Lab Immun Clin App2021; 28(9): 1447–1451.
10.
ShenHLuJJiangL, et al.Epidemiological investigation and related risk factors of diabetic foot in Nanchang area [J]. J Jiangxi College Tradit Chin Med2013; 25(4): 14–16+42.
11.
WangXZhangHJSuYL. Characteristics and related factors of diabetic foot in elderly patients [J]. Chin J Gerontol2013; 33(14): 3443–3444.
12.
XuHZWangRMWuJL. Retrospective analysis of 43 cases of diabetic foot ulcers [J]. Clin Med2009; 29(5): 15–16.
13.
CuiGMBanBQiaoQR, et al.Risk factors for diabetic foot ulcers [J]. Shandong Med2001; 6: 3–4.
14.
ShiYNiLLShiYN, et al.Risk factors for diabetic foot ulcers [J]. Medical Frontier2012; 22: 220–221.
15.
QianCChenTYuJH, et al.Correlation between inflammatory factors Lp-PLA2 and IL-18 and diabetic foot ulcers [J]. International Journal of laboratory medicine2020; 41(2): 163–167.
16.
LiHYZhaoPAnXR. Risk factors and clinical significance of preventive examination for diabetic foot ulcers [J]. Pract Prevent Med2013; 20(2): 240–241.
17.
YangXHYuYSuiM, et al.Clinical characteristics and risk factors of diabetic foot ulcers [J]. Chin J Gerontol2013; 33(13): 3213–3214.
18.
YangHY. Clinical characteristics and risk factors of diabetic foot ulcers [J]. J Mudanjiang Med College2019; 40(6): 81–82+140.
19.
ZhangY.Clinical analysis of type 2 diabetic foot ulcers [J]. J Hunan Univ Tradit Chin Med2013; 33(6): 22–23.
20.
SunZJ. Investigation of risk factors for the development of diabetic foot in patients with type 2 diabetes mellitus[J]. Dermatol Venereal Dis2020; 42(2): 257–258.
21.
TangJYangSY. Analysis of factors influencing the complications of diabetic foot in patients with type 2 diabetes [J]. Chin Med Innov2022; 19(8): 120–123.
22.
JiangWPOuyangJCiH, et al.Analysis of risk factors for diabetic foot ulcers and observation of ultrasonic debridement efficacy [J]. Jilin Med2019; 40(10): 2326–2327.
23.
TeenaRDhamodharanUAliD, et al.Genetic polymorphism of the Nrf2 promoter region (rs35652124) is associated with the risk of diabetic foot Ulcers. Oxid Med Cell Longev2020; 2020: 9825028.
24.
GonzálezRPedroTRealJT, et al.Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev2010; 26(2): 115–120.
25.
YazdanpanahLShahbazianHNazariI, et al.Incidence and risk factors of diabetic foot Ulcer: a population-based diabetic foot cohort (ADFC study)-two-year follow-up study. Int J Endocrinol2018; 2018: 7631659.
26.
ZubairMMalikAMeerzaD, et al.25-Hydroxyvitamin D [25(OH)D] levels and diabetic foot ulcer: is there any relationship?Diabetes Metab Syndr2013; 7(3): 148–153.
27.
BadediMDarrajHHummadiA, et al.Vitamin B12 deficiency and foot Ulcers in type 2 diabetes mellitus: a case-control study. Diabetes Metab Syndr Obes2019; 12: 2589–2596.
28.
RossbothSRossbothBSchoenherrH, et al.Risk factors for diabetic foot complications among patients with type 2 diabetes in Austria-A registry-based retrospective cohort study. Endocrinol Diabetes Metab2021; 4(4): e00286.
29.
ZhangKDingSLyuX, et al.Correlation between the platelet-to-lymphocyte ratio and diabetic foot ulcer in patients with type 2 diabetes mellitus. J Clin Lab Anal2021; 35(4): e23719.
30.
WeiHWangMDLiFL. Effect of hyperbaric oxygen on diabetic foot ulcers and plasma fibrinolytic system [J]. Chongqing Med2012; 19(3): 213–215.
31.
AnJSZhaoJWangXY. Analysis of factors affecting amputation of severe diabetic foot and diabetic foot [J]. Chin General Med2018; 21(26): 3194–3200.
32.
WuRBaiJJZhouJ, et al.Investigation and analysis of pre hospital diagnosis and treatment for elderly diabetic foot patients [J]. Geriatr Health Care2020; 26(2): 283–286.
33.
BruunCSiersmaVGuassoraAD, et al.Amputations and foot ulcers in patients newly diagnosed with type2 diabetes mellitus and observed for 19 years. the role of age, gender and co-morbidity. Diabet Med2013; 30(8): 964–972.
34.
Haji ZaineNBurnsJVicarettiM, et al.Characteristics of diabetic foot ulcers in Western SydneyAustralia[J]. J Foot Ankle Res2014; 7(1): 39–45.
35.
XuZRanX. Diabetic foot care in China: challenges and strategy. Lancet Diabetes Endocrinol2016; 4(4): 297–298.
36.
ZhangR. Role and intervention of endothelial progenitor cells in diabetic angiopathy [J]. Int J Pathol Sci Clin2009; 29(4): 353–356.
37.
WuHQChenGLuW. Basic knowledge education and prevention of diabetic foot [J]. J Pract Cardio Cerebrovasc Dis2010; 18(5): 572.
38.
LiuSWLiBCYangJL. Analysis of risk factors for promoting diabetic foot [J]. Chin J of Misdiagnos2008; 22: 5317–5318.
39.
ChengYJGreggEWKahnHS, et al.Peripheral insensate neuropathy—a tall problem for US adults?Am J Epidemiol2006; 164(9): 873–880.
40.
LiuXQLiJH. Risk factors and predilection sites of diabetic foot ulcers [J]. Hubei J Trad Chin Med2019; 41(4): 47–50.
41.
WangZHuKSuH, et al.Risk prevention measures for diabetic foot ulcers in Britain, Germany and France[J]. Leather Sci Eng2017; 27(2): 33–39.
42.
DekkerRGIIQinCHoBS, et al.The effect of cumulative glycemic burden on the incidence of diabetic foot disease. J Orthop Surg Res2016; 11(1): 143.
43.
Assaad-KhalilSHZakiARehimAA, et al.Prevalence of diabetic foot disorders and related risk factors among Egyptian subjects with diabetes[J]. Prim Care Diab2015; 9(4): 297–303.
44.
FengHTLiHP. Relationship between insulin resistance and risk of lower extremity atherosclerosis in patients with type 2 diabetes mellitus [J]. Chongqing Med2016; 45(36): 5170–5172.
45.
Chinese Medical Association Diabetes Association microvascular complications group. Clinical guidelines for diabetic nephropathy in China[J]. Chin J Diabetes2019; 11(1): 15–28.
46.
ChenHZLinGWWangJY. Practical Internal Medicine [M]. Beijing People’s Health Publishing House, 2014, pp. 1008–1010.
47.
Chinese Diabetes Society. Guidelines for prevention and treatment of type 2 diabetes in China [J]. China Diabetes J2014; 22(8): 96.
48.
WangHFPuDChenBA, et al.Clinical analysis of diabetic foot [J]. Liaoning J Pract Diab2001; 1: 44–45.
49.
HanJYuJDYaoQ, et al.Effect of Huoxue Jiedu Recipe on PKC and MDA in rats with diabetic peripheral neuropathy [J]. Shanghai J Tradit Chin Med2012; 46(9): 76–80.
50.
HuYYLiQM. Progress in pathogenesis of diabetic peripheral neuropathy [J]. Med Rev2016; 22(20): 4050–4053.
51.
DuanHLiuGTSunHW, et al.Relationship between erythrocyte sedimentation rate, C reactive protein, diabetic peripheral neuropathy and severity of diabetic foot ulcers [J]. Electron J Foot Ankle Surg2021; 8(1): 22–26.
52.
ZhaoHWNanXSTongZZ, et al.Correlation analysis between diabetic foot and diabetic retinopathy [J]. PLA Med J2016; 28(9): 17–20.
53.
LuJLiCXQinY, et al.Study on the correlation between diabetic retinopathy and diabetic foot [J]. Electron J Clin Med Literature2016; 3(40): 7928–7929.
54.
GuP. Correlation between diabetic microvascular disease and diabetic foot ulcers [J]. New World Diabetes2016; 19(17): 109–110.
55.
LeeseGSchofieldCMcmurrayB, et al.Scottish foot ulcer risk score predicts foot ulcer healing in a regional specialist foot clinic [J]. Diabetes Care2007; 30(8): 2064–2069.
56.
MarxN. New ESC guidelines 2019 “Diabetes, prediabetes and cardiovascular diseases”: paradigm shift in reduction of cardiovascular risk in patients withdiabetes mellitus[J]. Herz2019; 44(8): 684–687.
57.
SchaperNC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev2004; 20(suppl 1): S90–S95.
58.
FeiYFWangCChenDW, et al.Incidence and risk factors of amputation among inpatients with diabetic foot [in Chinese]. Zhonghua Yi Xue Za Zhi2012; 92: 1686–1689.
59.
WangNYangBHWangG, et al.A meta-analysis of the relationship between foot local characteristics and major lower extremity amputation in diabetic foot patients. J Cell Biochem2019; 120: 9091–9096.
60.
WuJLiuMHuangH. Risk factors associated with diabetic foot ulcers and its relationship with ABI and Brachial-Ankle Pulse wave velocity. Int J Low Extrem Wounds2021; 21: 609–616.
61.
ZuberiSISyedEUBhattiJA. Association of depression with treatment outcomes in type 2 diabetes mellitus: a cross-sectional study from Karachi, Pakistan[J]. BMC Psychiat2011; 11(1): 27–32.
62.
PengYG. Study on pathogenesis of diabetic peripheral neuropathy [J]. Chin Med Guide2014; 12(17): 397–398.
63.
YueZXZengHCXieCG, et al.Progress in etiology of diabetic vascular complications[J]. Modern Clin Med2012; 38(4): 247–250.
64.
PatelAMacMahonSChalmersJ, et al.Advance collaborative group. Intensive blood glucose control and vascular outcomes in pa-tients with type 2 diabetes[J]. N Engl J Med2008; 358(24): 2560–2572.
65.
CarterRELacklandDTClearyPA, et al.Intensive treatment of dia- betes is associated with a reduced rate of peripheral arterial calcifica-tion in the diabetes control and complications trial[J]. Diabetes Care2007; 30(1): 2646–2648.
66.
WeinertLSPratesABdo AmaralFB, et al.Gender does not influence cystatin C concentrations in healthy volunteers[J]. Clin Chem Lab Med2010; 48(3): 405–408.
67.
MichaudDSGalloVSchlehoferB, et al.Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study[J]. Cancer Epidemiol Biomarkers Prev2010; 19(10): 2562–2569.
68.
ZhouXJWangDHYangGM, et al.Relationship between plasma fibrinogen and platelet counts and diabetic foot and prognosis [J]. J Hubei Med College2013; 32(6): 492–494+506.
69.
Preston-MartinSHendersonBEBernsteinL. Medical and dental x-rays as risk factors for recently diagnosed tumors of the head[J]. Natl Cancer Inst Monogr1985; 69(8): 175–179.
70.
DuanHLiuGTSunHW, et al.Relationship between erythrocyte sedimentation rate, C reactive protein, diabetic peripheral neuropathy and severity of diabetic foot ulcers [J]. Electron J foot ankle surg2021; 8(1): 22–26.
71.
BlitshteynSCrookJEJaeckleKA. Is there an association between meningioma and hormone replacement therapy? [J]J Clin Oncol2008; 26(2): 279–282.
72.
GazzeriRGalarzaMGazzeriG. Growth of a meningioma in a transsexual patient after estrogen-progestin therapy[J]. N Engl J Med2007; 357(23): 2411–2412.
